Skip to main content
. 2024 Apr 22;20(4):e1011235. doi: 10.1371/journal.pgen.1011235

Fig 8. Macrophage subtypes of anti-PD-1 resistance in NSCLC.

Fig 8

Gene set enrichment analysis of anti-PD 1 treatment for NSCLC showed that patients in complete remission (CR) and partial remission (PR) compared with those in patients with progressive disease (PD).